REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 189 filers reported holding REATA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $70,000 | -16.7% | 1,506 | -45.6% | 0.00% | – |
| Q2 2022 | $84,000 | +40.0% | 2,768 | +51.1% | 0.00% | – |
| Q1 2022 | $60,000 | +25.0% | 1,832 | 0.0% | 0.00% | – |
| Q4 2021 | $48,000 | -20.0% | 1,832 | +208.4% | 0.00% | – |
| Q3 2021 | $60,000 | +13.2% | 594 | +60.1% | 0.00% | – |
| Q2 2021 | $53,000 | -27.4% | 371 | -49.2% | 0.00% | – |
| Q1 2021 | $73,000 | -38.1% | 731 | -23.1% | 0.00% | – |
| Q4 2020 | $118,000 | +4.4% | 951 | -18.0% | 0.00% | – |
| Q3 2020 | $113,000 | -91.7% | 1,160 | -86.7% | 0.00% | -100.0% |
| Q2 2020 | $1,365,000 | -19.6% | 8,750 | -25.6% | 0.00% | -33.3% |
| Q1 2020 | $1,697,000 | -29.4% | 11,761 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $2,405,000 | – | 11,761 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |